WAM
MRNA icon

Warberg Asset Management’s Moderna MRNA Stock Holding History

Warberg Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,000
Closed -$267K – 215
2024
Q3 		$267K Hold
4,000
– – 0.05% 111
2024
Q2 		$475K Hold
4,000
– – 0.07% 90
2024
Q1 		$426K Sell
4,000
-2,000
-33% -$202K 0.06% 82
2023
Q4 		$597K Sell
6,000
-8,000
-57% -$673K 0.11% 71
2023
Q3 		$1.45M Buy
14,000
+8,000
+133% +$892K 0.29% 41
2023
Q2 		$729K Buy
+6,000
New +$800K 0.12% 54
2022
Q1 		– Sell
-1,600
Closed -$406K – 244
2021
Q4 		$406K Sell
1,600
-7,400
-82% -$2.16M 0.08% 83
2021
Q3 		$3.46M Buy
+9,000
New +$3.32M 0.56% 32

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Warberg Asset Management's MRNA Position: Q4 2024 in Review

Warberg Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,500 shares — an estimated $234K sold.

Warberg Asset Management first reported a position in MRNA in Q4 2021 and held it in 3 quarters. The position peaked at $381K in Q4 2021. 747 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Warberg Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Warberg Asset Management sold 3,500 Moderna shares in Q4 2024, an estimated $234K.
  • Warberg Asset Management first reported a position in Moderna in Q4 2021 and held it in 3 quarters.
  • Warberg Asset Management's Moderna position peaked at $381K in Q4 2021.
  • 747 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Warberg Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.